Biostage, Inc.
BSTG · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $270 | $24 | $0 | $0 |
| Gross Profit | -$270 | -$24 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,310 | $3,062 | $1,742 | $1,592 |
| G&A Expenses | $5,022 | $5,713 | $4,411 | $7,044 |
| SG&A Expenses | $5,576 | $6,007 | $4,411 | $7,044 |
| Sales & Mktg Exp. | $554 | $294 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $70 |
| Operating Expenses | $7,886 | $9,069 | $6,153 | $8,471 |
| Operating Income | -$8,156 | -$9,093 | -$6,153 | -$8,636 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $424 | $71 | $80 | $493 |
| Pre-Tax Income | -$7,732 | -$9,022 | -$6,073 | -$7,978 |
| Tax Expense | $0 | $0 | $6,253 | -$530 |
| Net Income | -$7,732 | -$9,022 | -$6,073 | -$7,978 |
| % Margin | – | – | – | – |
| EPS | -0.52 | -0.67 | -1.09 | -0.74 |
| % Growth | 22.4% | 38.5% | -47.3% | – |
| EPS Diluted | -0.52 | -0.67 | -1.09 | -0.74 |
| Weighted Avg Shares Out | 14,789 | 13,456 | 11,350 | 10,062 |
| Weighted Avg Shares Out Dil | 14,789 | 13,456 | 11,350 | 10,062 |
| Supplemental Information | – | – | – | – |
| Interest Income | $32 | $64 | $0 | $0 |
| Interest Expense | -$38 | -$14 | $100 | $0 |
| Depreciation & Amortization | $0 | $0 | $50 | -$258 |
| EBITDA | -$8,156 | -$9,093 | -$5,923 | -$8,894 |
| % Margin | – | – | – | – |